129 related articles for article (PubMed ID: 7795994)
1. Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia.
Robinson MH; Kronborg O; Williams CB; Bostock K; Rooney PS; Hunt LM; Hardcastle JD
Br J Surg; 1995 Mar; 82(3):318-20. PubMed ID: 7795994
[TBL] [Abstract][Full Text] [Related]
2. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests.
Robinson MH; Marks CG; Farrands PA; Thomas WM; Hardcastle JD
Br J Surg; 1994 Mar; 81(3):448-51. PubMed ID: 8173928
[TBL] [Abstract][Full Text] [Related]
3. Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.
Hunt LM; Rooney PS; Bostock K; Robinson MH; Hardcastle JD; Armitage NC
Gut; 1997 Jan; 40(1):110-2. PubMed ID: 9155586
[TBL] [Abstract][Full Text] [Related]
4. Chemical and immunological testing for faecel occult blood: a comparison of two tests in symptomatic patients.
Thomas WM; Hardcastle JD; Jackson J; Pye G
Br J Cancer; 1992 Apr; 65(4):618-20. PubMed ID: 1562472
[TBL] [Abstract][Full Text] [Related]
5. Is an immunological faecal occult blood test better than Haemoccult? A cost-benefit study.
Robinson MH; Marks CG; Farrands PA; Whynes DK; Bostock K; Hardcastle JD
Eur J Surg Oncol; 1995 Jun; 21(3):261-4. PubMed ID: 7781793
[TBL] [Abstract][Full Text] [Related]
6. Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up.
Robinson MH; Marks CG; Farrands PA; Bostock K; Hardcastle JD
Br J Surg; 1996 Apr; 83(4):500-1. PubMed ID: 8665240
[TBL] [Abstract][Full Text] [Related]
7. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.
Thomas WM; Pye G; Hardcastle JD; Mangham CM
Br J Surg; 1990 Mar; 77(3):277-9. PubMed ID: 2322789
[TBL] [Abstract][Full Text] [Related]
8. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test.
Levi Z; Hazazi R; Rozen P; Vilkin A; Waked A; Niv Y
Aliment Pharmacol Ther; 2006 May; 23(9):1359-64. PubMed ID: 16629942
[TBL] [Abstract][Full Text] [Related]
9. A comparison of fecal occult-blood tests for colorectal-cancer screening.
Allison JE; Tekawa IS; Ransom LJ; Adrain AL
N Engl J Med; 1996 Jan; 334(3):155-9. PubMed ID: 8531970
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of new occult blood tests for detection of colorectal neoplasia.
St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
[TBL] [Abstract][Full Text] [Related]
11. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
[TBL] [Abstract][Full Text] [Related]
12. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
13. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
14. Faecal occult blood screening for colorectal neoplasia in a targeted high-risk population.
Caffarey SM; Broughton CI; Marks CG
Br J Surg; 1993 Nov; 80(11):1399-400. PubMed ID: 8252347
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Coloscreen Self-Test and Haemoccult faecal occult blood tests in the detection of colorectal cancer in symptomatic patients.
Pye G; Jackson J; Thomas WM; Hardcastle JD
Br J Surg; 1990 Jun; 77(6):630-1. PubMed ID: 2200550
[TBL] [Abstract][Full Text] [Related]
17. Role of dietary restriction in Haemoccult screening for colorectal cancer.
Thomas WM; Pye G; Hardcastle JD; Chamberlain J; Charnley RM
Br J Surg; 1989 Sep; 76(9):976-8. PubMed ID: 2679967
[TBL] [Abstract][Full Text] [Related]
18. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
19. Self-reported dark red bleeding as a marker comparable with occult blood testing in screening for large bowel neoplasms.
Silman AJ; Mitchell P; Nicholls RJ; Macrae FA; Leicester RJ; Bartram CI; Simmons MJ; Campbell PD; Hearn CE; Constable PJ
Br J Surg; 1983 Dec; 70(12):721-4. PubMed ID: 6605779
[TBL] [Abstract][Full Text] [Related]
20. Effect of faecal occult blood testing on colorectal cancer mortality in the surveillance of subjects at moderate risk of colorectal neoplasia: a case-control study.
Lamah M; Norris J; Caffarey SM; Broughton M; Marks CG
Int J Colorectal Dis; 2001 Sep; 16(5):313-7. PubMed ID: 11686530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
